Type IIA Secreted Phospholipase A2 in Host Defense against Bacterial Infections

Vincent P van Hensbergen, Yongzheng Wu, Nina M van Sorge, Lhousseine Touqui

Research output: Contribution to journalReview articlepeer-review

Abstract

The enzyme type IIA secreted phospholipase A2 (sPLA2-IIA) is crucial for mammalian innate host defense against bacterial pathogens. Most studies have investigated the role of sPLA2-IIA in systemic bacterial infections, identifying molecular pathways of bacterial resistance against sPLA2-IIA-mediated killing, and providing insight into sPLA2-IIA mechanisms of action. Sensitization of (antibiotic-resistant) bacteria to sPLA2-IIA action by blocking bacterial resistance or by applying sPLA2-IIA to treat bacterial infections might represent a therapeutic option in the future. Because sPLA2-IIA is highly expressed at mucosal barriers, we also discuss how sPLA2-IIA is likely to be an important driver of microbiome composition; we anticipate that future research in this area may bring new insights into the role of sPLA2-IIA in health and disease.

Original languageEnglish
Pages (from-to)313-326
Number of pages14
JournalTrends in immunology
Volume41
Issue number4
Early online date6 Mar 2020
DOIs
Publication statusPublished - Apr 2020

Keywords

  • antimicrobial enzyme
  • bacteria
  • infections
  • microbiome
  • phospholipase
  • virulence

Fingerprint

Dive into the research topics of 'Type IIA Secreted Phospholipase A2 in Host Defense against Bacterial Infections'. Together they form a unique fingerprint.

Cite this